Fungal infections are common among the general population and may be life-threatening, particularly for severely ill, immunocompromised and hospitalized patients. The proliferation of fungal strains can be triggered by antibiotic treatment necessitating the use of antifungal medicines. Without adequate treatment, fungal infections can become invasive, carrying a considerable economic cost and burden to health-care systems and patients.
Authors
- Citation
- World Health Organization. Regional Office for Europe . (2024). Action against antimicrobial resistance and fungal infections. World Health Organization. Regional Office for Europe. https://iris.who.int/handle/10665/379434 . License: CC BY-NC-SA 3.0 IGO
- Pages
- 2
- Published in
- Switzerland
- Rights
- CC BY-NC-SA 3.0 IGO
- Rights Holder
- World Health Organization
- Rights URI
- https://creativecommons.org/licenses/by-nc-sa/3.0/igo
Table of Contents
- Why pay attention to antimicrobial resistance AMR Why pay attention to fungal infections 1
- What are the WHO European Regions priorities regarding AMR and invasive fungal infections IFIs 1
- How can both areas benefit from each other 1
- Raising awareness on antifungal resistance through AMS training 2
- Achievements so far 2
